New Delhi: Leaders across pharma industries shared their views on innovation, technology and the potential learnings for the pharmaceutical industry and deliberated on achieving excellence and quality in operations, vaccine…
Sun Pharma, the country’s largest drugmaker, is looking for possible in-licensing opportunities and even acquisitions to bolster its global speciality business, a top executive said. “Organic efforts coupled with inorganic…
“FY23 should look largely normal again on a YoY deflation basis. This year, we have seen price deflations hoving around the high single digits – 8-9%. I hope that it…
MUMBAI: Sun Pharma said on Thursday it is gearing up to introduce antiviral Covid-19 drug, molnupiravir under the brand Molxvir at “an economical price” in India. Other companies including Hetero,…
